title: Sebaceous Carcinoma of the Eyelid.
abstract: BACKGROUND
  Periocular sebaceous carcinoma (PSC) is a rare but aggressive neoplasm that tends to clinically and histopathologically mimic other conditions. PSC can be challenging to diagnose using histomorphology alone given its overlap with 2 more common tumors that occur in this area (basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]). Use of immunohistochemistry can help resolve this differential diagnosis.
  
  
  METHODS
  A review of the literature was performed, focusing on the epidemiology, morphology, and immunohistochemical features of PSC.
  
  
  RESULTS
  The most useful immunostains in the differential diagnosis of PSC are epithelial membrane antigen, Ber-Ep4, androgen receptor (AR), and adipophilin. To discern PSC from BCC, one should use EMA, Ber-Ep4, AR, and adipophilin, whereas discerning PSC from SCC can be achieved by evaluating AR and adipophilin. In addition, p53 and ERBB2 (formally known as HER2/neu) are other potentially useful immunohistochemical markers for the differential diagnosis of PSC.
  
  
  CONCLUSIONS
  Use of new immunohistochemical techniques, as well as the elucidation of molecular alterations, such as the presence of ERBB2 amplification, will advance our understanding of PSC.
authors.affiliation: Department of Dermatology & Cutaneous Surgery, University of South Florida, Tampa, FL 33612, USA. cprietog@health.usf.edu.
authors.forename: Carlos
authors.initials: C
authors.lastname: Prieto-Granada
authors.forename: Paul
authors.initials: P
authors.lastname: Rodriguez-Waitkus
mesh_terms: D018266:Adenocarcinoma, Sebaceous / Q000473:pathology / Q000628:therapy*; D005142:Eyelid Neoplasms / Q000473:pathology / Q000628:therapy*; D005143:Eyelids / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry